Putting the Action in Long-Acting Antipsychotic Injections

Log in for full access to this session if you are registered.

Registration Options

Putting the Action in Long-Acting Antipsychotic Injections ~ Member Rate - $25.00
Putting the Action in Long-Acting Antipsychotic Injections - $30.00

Session Summary

Since the development and introduction of the long-acting antipsychotic medications in the 1960’s, clinical debates have occurred among health-care providers as to when these medications are appropriate to use.  The impact of poor medication adherence among patients with psychiatric disorders has a great impact on their clinical outcomes.  Long-acting injectable antipsychotics have been shown to reduce hospitalizations and to improve medication adherence.  The clinical pharmacologic properties, safety and tolerability profiles of these medications vary between agents.  This interactive session will provide the clinical health-care provider with practical knowledge of the long-acting antipsychotic medications including how to determine which medication is appropriate for a specific patient, and how to optimize pharmaceutical treatment, improve adherence and minimize drug-related problems.

Registrant Resources

Sorry, but you are not an authorized user. Please register for the course at the top of this page.

Faculty Information

Eric C. Kutscher, PharmD, BCPP

View biographical information and disclosures

Learning Objectives

  1. Describe the evidence and rationale for use of long-acting antipsychotics to prevent relapse in schizophrenia.
  2. Analyze the safety, pharmacokinetic and pharmaceutical properties of long-acting injectable antipsychotics to optimize outcomes in patients with schizophrenia.
  3. Formulate a care plan to address drug-related problems (e.g., titration schedules, polypharmacy, costs, etc.) associated with long-acting injectable antipsychotics.

Continuing Education Credit

Activity Dates: 05/01/2011 - 05/01/2014
ACPE Contact Hours: 1.0
ACPE Number: 0284-9999-11-004-H01-P (Application)
Nursing Credit Reminder: Note that ACPE and ACCME credit is accepted for certification renewal.

Course Requirements

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the medication therapy management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Grant Support

Supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC and Lilly USA, LLC.

This programming was supported in part by grants from Bristol-Myers Squibb, Cyberonics, Merk and Sunovion.